OncoMed Pharmaceuticals SVP/CFO on Emerging Company Capital Formation Testimony

Type:

Video

William D. Waddill, Senior Vice President and Chief Financial Officer of OncoMed Pharmaceuticals, highlights the importance of capital formation to encourage investment in the biotechnology industry and spur job growth. Mr. Waddill provided testimony today on behalf of BIO at a Senate Committee on Banking, Housing, and Urban Affairs hearing.

November 1, 2011 Repositioning Drugs for Parkinson's Disease	September 29, 2011 Dr. Paul Offit on the Importance of Vaccines and Impediments to Breakthroughs	September 28, 2011 Bernard Siegel of the Genetics Policy Institute Discusses Stem Cell Research	September 27, 2011 Becoming a Part of the Biotech Industry
September 12, 2011 2012 World Congress on Industrial Biotechnology and Bioprocessing	September 12, 2011 Podcast: Margaret Anderson, Executive Director of FasterCures	September 9, 2011 Contagion: How Would We Respond to a Pandemic?	September 9, 2011 Eva Jack, Chief Business Officer at Pulmatrix, on the Promise of Biotech